Bodhi Tree Biotechnology Inc (BDTB) Common Equity (2024 - 2026)

Bodhi Tree Biotechnology (BDTB) has reported Common Equity for 3 consecutive years, with $13823.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 89.35% year-over-year to $13823.0 in Q2 2026; TTM through Jun 2026 was $13823.0, a 89.35% decrease from a year earlier, with the FY2025 full-year figure at $119161.0, down 55.67% from the prior year.
• Common Equity was $13823.0 for Q2 2026 at Bodhi Tree Biotechnology, down from $66213.0 in the prior quarter.
• Over five years, Common Equity peaked at $268827.0 in Q3 2024 and troughed at $13823.0 in Q2 2026.
• A 3-year average of $136077.7 and a median of $129848.0 in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity slumped 55.67% in 2025 and slumped 89.35% in 2026, its largest moves.
• Over 3 years, Common Equity stood at $204050.0 in 2024, then tumbled by 67.55% to $66213.0 in 2025, then tumbled by 79.12% to $13823.0 in 2026.
• The last three Common Equity figures came in at $13823.0 (Q2 2026), $66213.0 (Q4 2025), and $119161.0 (Q3 2025), per Business Quant data.